Vestnik dermatologii i venerologii
ISSN 0042-4609 (Print)
ISSN 2313-6294 (Online)
Menu
Archives
Home
About the Journal
Editorial Team
Editorial Policies
Author Guidelines
About the Journal
Issues
Search
Current
Articles in press
Archives
Contact
Subscriptions
User
Username
Password
Remember me
Forgot password?
Register
Notifications
View
Subscribe
Search
Search
Search Scope
All
Authors
Title
Abstract
Index terms
Full Text
Browse
By Issue
By Author
By Title
By Sections
Keywords
C. trachomatis
acne
atopic dermatitis
children
cytokines
diagnostics
efficacy
isotretinoin
neurosyphilis
pathogenesis
psoriasis
psoriatic arthritis
rosacea
safety
syphilis
therapy
topical therapy
treatment
акне
атопический дерматит
псориаз
×
User
Username
Password
Remember me
Forgot password?
Register
Notifications
View
Subscribe
Search
Search
Search Scope
All
Authors
Title
Abstract
Index terms
Full Text
Browse
By Issue
By Author
By Title
By Sections
Keywords
C. trachomatis
acne
atopic dermatitis
children
cytokines
diagnostics
efficacy
isotretinoin
neurosyphilis
pathogenesis
psoriasis
psoriatic arthritis
rosacea
safety
syphilis
therapy
topical therapy
treatment
акне
атопический дерматит
псориаз
Home
>
Search
>
Author Details
Author Details
Artemeva, Antonina V.
Issue
Section
Title
File
Vol 97, No 4 (2021)
SCIENTTIFIC RESEARCHES
Efficacy and safety of netakimab, a novel anti-IL-17 monoclonal antibody, in patients with moderate to severe plaque psoriasis. Results of a 54-week randomized double-blind placebo-controlled PLANETA clinical trial
(Rus)
This website uses cookies
You consent to our cookies if you continue to use our website.
About Cookies
TOP
